Duration of therapy for tuberculosis in patients infected with Human Immunodeficiency Virus

  • Protocol
  • Intervention

Authors


Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

The aim of our systematic review is to assess the effects of an extended duration of the standard short course anti-tuberculosis chemotherapy (more than 6 months) on recurrence, cure, mortality, treatment failure, and adverse events in HIV-infected patients, using all available randomized controlled trials.